Herpes zoster after autologous hematopoietic stem cell transplantation.

about

Herpes zoster after autologous hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q39173692

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Herpes zoster after autologous hematopoietic stem cell transplantation.

@en

Herpes zoster after autologous hematopoietic stem cell transplantation.

@nl

type

Item

label

Herpes zoster after autologous hematopoietic stem cell transplantation.

@en

Herpes zoster after autologous hematopoietic stem cell transplantation.

@nl

prefLabel

Herpes zoster after autologous hematopoietic stem cell transplantation.

@en

Herpes zoster after autologous hematopoietic stem cell transplantation.

@nl

P1476

Herpes zoster after autologous hematopoietic stem cell transplantation.

@en

P2093

Abrahão Elias Hallack-Neto

http://www.w3.org/2001/XMLSchema#string

Angelo Atalla

http://www.w3.org/2001/XMLSchema#string

Kelli Borges Dos Santos

http://www.w3.org/2001/XMLSchema#string

Rafaela Souto E Souza

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma.

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.

Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.

Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.

Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.

Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation.

Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.

One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.

P304

298-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BJHH.2016.05.015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27863756

http://www.w3.org/2001/XMLSchema#string

P932

5119674

http://www.w3.org/2001/XMLSchema#string